Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$37.47
+0.7%
$32.81
$23.69
$37.65
$16.40B0.68941,554 shs484,378 shs
Solventum Corporation stock logo
SOLV
Solventum
$73.15
+0.7%
$73.76
$60.01
$85.92
$12.67B0.521.36 million shs821,204 shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€23.14
-1.4%
€24.22
€17.12
€28.00
€6.97B0.55356,268 shs254,200 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$106.11
+1.0%
$97.09
$89.22
$116.71
$21.02B0.681.72 million shs680,071 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.00%-0.16%+22.74%+29.39%+20.76%
Solventum Corporation stock logo
SOLV
Solventum
0.00%-0.43%+2.53%+0.15%+21.81%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%+2.75%-6.20%+4.94%+14.22%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.00%-1.41%+15.75%+15.19%-7.07%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.8838 of 5 stars
1.04.02.50.02.70.03.8
Solventum Corporation stock logo
SOLV
Solventum
2.3633 of 5 stars
3.13.00.00.02.90.01.3
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
3.0247 of 5 stars
0.04.00.80.03.10.03.1
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.6896 of 5 stars
2.25.01.73.72.92.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$36.00-3.93% Downside
Solventum Corporation stock logo
SOLV
Solventum
2.27
Hold$85.7517.23% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.83
Moderate BuyN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.35
Hold$111.445.02% Upside

Current Analyst Ratings Breakdown

Latest STVN, ZBH, SNN, and SOLV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$28.00 ➝ $36.00
8/8/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$91.00 ➝ $96.00
8/8/2025
Solventum Corporation stock logo
SOLV
Solventum
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$75.00 ➝ $79.00
8/8/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$87.00 ➝ $94.00
8/8/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$112.00 ➝ $115.00
8/8/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$104.00 ➝ $113.00
8/7/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
7/15/2025
Solventum Corporation stock logo
SOLV
Solventum
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$80.00 ➝ $103.00
7/15/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$135.00
7/8/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$102.00 ➝ $96.00
7/1/2025
Solventum Corporation stock logo
SOLV
Solventum
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$90.00
(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$5.81B2.82$3.16 per share11.86$12.64 per share2.96
Solventum Corporation stock logo
SOLV
Solventum
$8.25B1.54$9.95 per share7.35$21.02 per share3.48
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.19B5.87€0.76 per share30.48€5.24 per share4.42
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.83B2.68$13.20 per share8.04$63.27 per share1.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$412M$2.1617.3518.741.03N/AN/AN/AN/A
Solventum Corporation stock logo
SOLV
Solventum
$478M$2.1633.8613.321.774.52%29.93%6.65%11/6/2025 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€127.45M€0.5442.8539.902.1711.73%10.34%6.21%N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.1125.8211.962.0910.51%12.76%7.21%10/29/2025 (Estimated)

Latest STVN, ZBH, SNN, and SOLV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Solventum Corporation stock logo
SOLV
Solventum
$1.45$1.69+$0.24$0.51$2.12 billion$2.16 billion
8/7/2025Q2 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.98$2.07+$0.09$0.77$2.06 billion$2.08 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.892.38%N/A41.20%N/A
Solventum Corporation stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.90%N/A23.36%N/A

Latest STVN, ZBH, SNN, and SOLV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/5/2025
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
semi-annual$0.28502.1%10/3/202510/3/202511/7/2025
8/27/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.89%9/30/20259/30/202510/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.60
3.00
1.40
Solventum Corporation stock logo
SOLV
Solventum
2.14
1.22
0.86
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.25
1.79
1.22
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.54
1.87
0.96

Institutional Ownership

CompanyInstitutional Ownership
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%
Solventum Corporation stock logo
SOLV
Solventum
N/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
Solventum Corporation stock logo
SOLV
Solventum
0.05%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.70%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
1.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
17,349437.98 million433.60 millionOptionable
Solventum Corporation stock logo
SOLV
Solventum
22,000173.39 million173.30 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
5,521302.84 million300.72 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
17,000198.10 million195.34 millionOptionable

Recent News About These Companies

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Zimmer Biomet adds duo of new chief medical advisors

New MarketBeat Followers Over Time

Media Sentiment Over Time

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$37.47 +0.24 (+0.65%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$37.45 -0.02 (-0.06%)
As of 08/29/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Solventum stock logo

Solventum NYSE:SOLV

$73.15 +0.49 (+0.67%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$72.50 -0.65 (-0.89%)
As of 08/29/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€23.14 -0.32 (-1.36%)
As of 08/29/2025 03:58 PM Eastern

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$106.11 +1.05 (+1.00%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$106.18 +0.07 (+0.07%)
As of 08/29/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.